ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hohlfeld, J
Right arrow Articles by Heinrich, U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohlfeld, J
Right arrow Articles by Heinrich, U
Eur Respir J 1997; 10: 2198-2203
Copyright © ERS Journals Ltd 1997


Original Articles

Aerosolized surfactant inhibits acetylcholine-induced airway obstruction in rats

J Hohlfeld, HG Hoymann, J Molthan, H Fabel, and U Heinrich

Exogenous surfactant treatment inhibits antigen-induced airway obstruction in sensitized guinea-pigs. Aerosolized surfactant also improves respiratory function in asthmatic patients. The aim of the present study was to determine whether aerosolized surfactant inhibits nonallergic airway obstruction induced by acetylcholine. Anaesthetized Wistar rats were treated by aerosol with the beta2-adrenoceptor agonist terbutaline, surfactant (Alveofact), a surfactant-terbutaline combination, or vehicle (control). Animals were then challenged by aerosolized acetylcholine to elicit receptor-mediated airway obstruction. A second group of animals was challenged with intravenous acetylcholine. Respiratory function variables were measured by body plethysmography before and after treatment, and after the acetylcholine challenge. Baseline lung function values before and after treatment were similar in all groups. Acetylcholine challenge by aerosol increased lung resistance by 64% in control animals. Pretreatment with terbutaline and surfactant significantly limited the increase of lung resistance to +36 and +34%, respectively. Simultaneous aerosolization of surfactant and terbutaline also inhibited airway obstruction but their effects were not additive. By contrast, terbutaline treatment inhibited the effects of intravenous acetylcholine, but surfactant did not. In conclusion, we suggest that surfactant aerosol may prevent acetylcholine and other pharmacological agents from reaching the airway smooth muscle from the airway lumen but not via the bloodstream.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Koetzler, M. Saifeddine, Z. Yu, F.S. Schurch, M. D. Hollenberg, and F. H. Y. Green
Surfactant as an Airway Smooth Muscle Relaxant
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. M. Hohlfeld, H. G. Hoymann, T. Tschernig, A. Fehrenbach, N. Krug, and H. Fehrenbach
Keratinocyte growth factor transiently alters pulmonary function in rats
J Appl Physiol, February 1, 2004; 96(2): 704 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Glaab, H. G. Hoymann, J. M. Hohlfeld, R. Korolewitz, M. Hecht, Y. Alarie, T. Tschernig, A. Braun, N. Krug, and H. Fabel
Noninvasive measurement of midexpiratory flow indicates bronchoconstriction in allergic rats
J Appl Physiol, October 1, 2002; 93(4): 1208 - 1214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.